Table 9. Statistical analysis for the contralateral rotations following administration of A2A and NR2B receptor antagonist combinations as add-on treatment to l-Dopa.
A2A antagonist | NR2B antagonist | A2A×NR2B interaction | Comments | |
Sch-58261 | Co-101244 | Combination | Additive effect | |
Drugs main effecta | p<0.05 | Not significant | Not significant | between |
Drugs × Time effecta | p<0.001 | p<0.001 | Not significant | Sch-58261 |
Combination vs vehicleb | p<0.05 for 30′ | And | ||
Drugs alone vs vehicleb | Sch-58261, p<0.05 for 10′ | Co-101244 | ||
Preladenant | Merck 22 | Combination | Additive effect | |
Drugs main effecta | p<0.05 | Not significant | Not significant | between |
Drugs × Time effecta | p<0.001 | p<0.01 | Not significant | Preladenant |
Combination vs vehicleb | p<0.05 for 40′ | and | ||
Drugs alone vs vehicleb | Not significant | Merck 22 | ||
Preladenant | Radiprodil | Combination | Additive effect | |
Drugs main effecta | p<0.01 | Not significant | Not significant | between |
Drugs × Time effecta | p<0.001 | p<0.01 | Not significant | Preladenant |
Combination vs vehicleb | p<0.05 for 40′ | and | ||
Drugs alone vs vehicleb | Not significant | Radiprodil | ||
Tozadenant | Radiprodil | Combination | Additive effect | |
Drugs main effecta | p<0.001 | p<0.01 | Not significant | between |
Drugs × Time effecta | p<0.001 | p<0.001 | Not significant | Tozadenant |
Combination vs vehicleb | p<0.05 for 120′ | and | ||
Drugs alone vs vehicleb | Tozadenant p<0.05 for 80′ | Radiprodil | ||
Radiprodil p<0.05 for 20′ |
Primary statistical analyses conducted via Three-way mixed ANOVA;
A priori Planned Contrasts done on each.
10-min time interval of rotations recording.